Bundamedik Tbk PT
IDX:BMHS
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
240
378
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Bundamedik Tbk PT
Net Margin
Bundamedik Tbk PT
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | ID |
| Market Cap | 2.3T IDR |
| Net Margin |
1%
|
| Country | US |
| Market Cap | 83.9B USD |
| Net Margin |
9%
|
| Country | SA |
| Market Cap | 98B SAR |
| Net Margin |
22%
|
| Country | ZA |
| Market Cap | 24.9B Zac |
| Net Margin |
17%
|
| Country | ZA |
| Market Cap | 20.7B Zac |
| Net Margin |
5%
|
| Country | CN |
| Market Cap | 133.2B CNY |
| Net Margin |
18%
|
| Country | MY |
| Market Cap | 63.3B MYR |
| Net Margin |
11%
|
| Country | US |
| Market Cap | 13.7B USD |
| Net Margin |
15%
|
| Country | US |
| Market Cap | 13.1B USD |
| Net Margin |
7%
|
| Country | TH |
| Market Cap | 421.1B THB |
| Net Margin |
15%
|
| Country | IN |
| Market Cap | 997.2B INR |
| Net Margin |
5%
|
Bundamedik Tbk PT
Glance View
PT Bundamedik Tbk is a holding company, with engages in the provision of healthcare and medical technology services. The company is headquartered in Jakarta Pusat, Dki Jakarta and currently employs 1,285 full-time employees. The company went IPO on 2021-07-06. The firm is engaged in private hospital activities, private polyclinic activities, and other hospital activities. The Company’s also offers other hospital activities, such as healthcare services activities performed by paramedics and health support service activities. The firm operates two general clinics in Jakarta and Bekasi that offer services, such as obstetrics and gynecology specialist poly, child specialist poly, skin and aesthetic poly, dental and oral poly, general poly, medical check-ups, internal medicine poly, poly nutrition, and pharmacy. The company offers a range of services, such as mother and child services, outpatient services, inpatient services, in vitro fertilization (IVF) services, and clinical laboratory services. The firm operates approximately two maternal and child hospitals, three general hospitals, 10 IVF clinics, 14 laboratories and various other supporting business activities.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Bundamedik Tbk PT's most recent financial statements, the company has Net Margin of 0.8%.
You don't have any saved screeners yet
